Baker Ellis Asset Management’s GSK GSK Stock Holding History

Baker Ellis Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,400	Closed	-$128K	–	229
2019 Q3	$128K	Hold	2,400	–	–	0.03%	205
2019 Q2	$120K	Hold	2,400	–	–	0.03%	210
2019 Q1	$125K	Hold	2,400	–	–	0.03%	194
2018 Q4	$115K	Hold	2,400	–	–	0.03%	200
2018 Q3	$121K	Sell	2,400 -120	-5%	-$6.1K	0.03%	220
2018 Q2	$127K	Hold	2,520	–	–	0.03%	218
2018 Q1	$123K	Hold	2,520	–	–	0.03%	222
2017 Q4	$112K	Hold	2,520	–	–	0.03%	232
2017 Q3	$128K	Hold	2,520	–	–	0.03%	220
2017 Q2	$136K	Hold	2,520	–	–	0.04%	216
2017 Q1	$133K	Sell	2,520 -174	-6%	-$8.83K	0.04%	220
2016 Q4	$130K	Buy	2,694 +294	+12%	+$14.5K	0.04%	219
2016 Q3	$129K	Hold	2,400	–	–	0.04%	220
2016 Q2	$130K	Hold	2,400	–	–	0.04%	213
2016 Q1	$122K	Hold	2,400	–	–	0.04%	220
2015 Q4	$121K	Hold	2,400	–	–	0.04%	226
2015 Q3	$115K	Hold	2,400	–	–	0.04%	229
2015 Q2	$125K	Hold	2,400	–	–	0.04%	238
2015 Q1	$138K	Hold	2,400	–	–	0.04%	232
2014 Q4	$128K	Hold	2,400	–	–	0.04%	224
2014 Q3	$138K	Hold	2,400	–	–	0.05%	226
2014 Q2	$160K	Hold	2,400	–	–	0.05%	219
2014 Q1	$160K	Hold	2,400	–	–	0.06%	224
2013 Q4	$160K	Hold	2,400	–	–	0.06%	221
2013 Q3	$151K	Hold	2,400	–	–	0.06%	219
2013 Q2	$150K	Buy	+2,400	New	+$152K	0.06%	215

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Baker Ellis Asset Management's GSK Position: Q4 2019 in Review

Baker Ellis Asset Management sold out of GSK (GSK) in Q4 2019, closing a stake of 2,400 shares — an estimated $128K sold.

Baker Ellis Asset Management first reported a position in GSK in Q2 2013 and held it in 26 quarters. The position peaked at $160K in Q2 2014. 894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

Baker Ellis Asset Management reported no remaining GSK position as of Q4 2019 after selling out during the quarter.
Baker Ellis Asset Management sold 2,400 GSK shares in Q4 2019, an estimated $128K.
Baker Ellis Asset Management first reported a position in GSK in Q2 2013 and held it in 26 quarters.
Baker Ellis Asset Management's GSK position peaked at $160K in Q2 2014.
894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Baker Ellis Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.